Compare tool
CJC-1295 (No DAC) vs Tesamorelin
Same attributes, same format, up to four peptides. Then let the advisor explain the trade-offs in plain language.
Peptide C
Educational only, not medical advice.
| Attribute | CJC-1295 (No DAC) Anti-Aging & Longevity | Tesamorelin Growth Hormone Optimization |
|---|---|---|
| Route | Subcutaneous | Subcutaneous |
| Dose range | 1 mg – 2 mg | 1 mg – 2 mg |
| Frequency | Once per week (subcutaneous). | Once per day (subcutaneous), preferably in the evening. |
| Timing | Evening administration (pre-bed) may synergize with natural nocturnal GH release. | Evening administration; rotate sites to reduce local irritation. |
| Cycle length | 8–12 weeks. | 12–26 weeks. |
| Vial options | 5 mg, 5 mg, 2 mg | 5 mg, 10 mg, 20 mg |
| Studied benefits | A GHRH analog that increases plasma GH levels by stimulating the pituitary gland. It is preferred for those who want a shorter half-life that mimics the body’s natural pulsatile release, leading to better fat metabolism and skin quality. | Effectively reduces visceral (abdominal) fat and may improve lipid profiles. There is also emerging research regarding its potential to enhance cognitive function in older adults. |
| Reported side effects | Occasional "head rush" or flushing shortly after administration. Long-term use is generally well-tolerated with proper site rotation. | Common side effects include joint pain, muscle aches, and mild swelling (edema). It may also lead to "carpal tunnel-like" symptoms (tingling in hands) and requires monitoring of blood sugar (HbA1c) and IGF-1 levels. Contraindicated in those with active malignancies. |
| Cited studies | 11 | 8 |
| N1 Aminos | from $55.00 → Code DOSING15 · 15% off first order | from $69.00 → Code DOSING15 · 15% off first order |
| Calculator | Do the math | Do the math |
AI explanation
Click “Explain the trade-offs” for a plain-language read on mechanism, dosing scale, side-effect profile and research depth.
CJC-1295 (No DAC) vs Tesamorelin